comparemela.com

Latest Breaking News On - Judithb resnick - Page 1 : comparemela.com

Neuron Model Paves Way For New Alzheimer's Therapies

Neuron Model Paves Way For New Alzheimer's Therapies
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Judithb-resnick
Shiaoching-gong
Celeste-parra-bravo
Heather-lindsey
National-institute
Weill-cornell-graduate-school-of-medical-sciences
National-institute-of-neurological-disorders
Robert-appel-alzheimer-disease-research-institute
National-institute-on
Tau-consortium
Appel-institute
National-institutes-of-health

Neuron model paves way for new Alzheimer's therapies

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain – a process that drives cognitive decline in Alzheimer’s disease and frontotemporal dementia.

Shiaoching-gong
Celeste-parra-bravo
Judithb-resnick
Weill-cornell-graduate-school-of-medical-sciences
National-institute
Tau-consortium
National-institutes-of-health
National-institute-of-neurological-disorders
Appel-institute
National-institute-on
Research-institute
Robert-appel-alzheimer-disease-research-institute

Human neuron model identifies potential therapeutic targets for Alzheimer's disease

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain-;a process that drives cognitive decline in Alzheimer's disease and frontotemporal dementia.

Celeste-parra-bravo
Shiaoching-gong
Judithb-resnick
Robert-appel-alzheimer-disease-research-institute
Appel-institute
Weill-cornell-graduate-school-of-medical-sciences
Cornell-medicine
Robert-appel-alzheimer
Disease-research-institute
Distinguished-professor
Neurodegenerative-diseases
Feil-family-brain

Targeting antiviral pathway may offer a new approach to fight Alzheimer's, frontotemporal dementia

Targeting part of an antiviral pathway triggered by the accumulation of a key pathogen shared in Alzheimer's disease and frontotemporal dementia may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.

Judithb-resnick
Sadaf-amin
Yige-huang
Emily-henderson
Robert-appel-alzheimer-disease-research-institute
Weill-cornell-graduate-school-of-medical-sciences
Weill-cornell-medicine
Nature-neuroscience
Robert-appel-alzheimer
Disease-research-institute
Distinguished-professor
Neurodegenerative-diseases

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.